The effectiveness of intravenous thrombolysis has been well-documented. Studies show that early administration of thrombolytic agents like tissue plasminogen activator (tPA) within a 4.5-hour window from the onset of stroke symptoms can drastically improve outcomes. However, the effectiveness decreases as the time to treatment increases.
